Curated Information
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.8.0
Powered by Cell Signaling Technology
Home > Curated Information Page > PubMed Id: 38260548
Tey PY, et al. (2024) Rapid turnover of CTLA4 is associated with a complex architecture of reversible ubiquitylation. bioRxiv 38260548
This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.
Click on the protein name to open the protein page, and on the RSD number to open the site page.
Download

K203-ub - CTLA-4 (human)
Modsite: LTTGVyVkMPPTEPE SwissProt Entrez-Gene
Orthologous residues
CTLA‑4 (human): K203‑ub, CTLA‑4 (mouse): K203‑ub, CTLA‑4 (rat): K203‑ub
Characterization
Methods used to characterize site in vivo immunoprecipitation, western blotting
Disease tissue studied:  melanoma skin cancer
Relevant cell lines - cell types - tissues:  A2058 (keratinocyte), HeLa S3 Flp-In, T lymphocyte-spleen
Cellular systems studied:  primary cells
Species studied:  human, mouse
Upstream Regulation
Potential in vivo enzymes for site: 
Type Enzyme Evidence Notes
DEUBIQUITINASE USP8 (human) transfection of inactive enzyme, transfection of wild-type enzyme, co-immunoprecipitation, siRNA inhibition of enzyme
Comments:  K63, K27, and K29 linkages mixture may contribute to the rapidity of protein turnover
Downstream Regulation
Effect of modification (function):  enzymatic activity, induced, protein degradation
Comments:  Catalytic activity and endosomal localization of USP8 are necessary for CTLA-4 deubiquitylation of K63,K27, and K29 linked attached chains for degradation, and rapid turnover of CTLA-4

K213-ub - CTLA-4 (human)
Modsite: PTEPECEkQFQPyFI SwissProt Entrez-Gene
Orthologous residues
CTLA‑4 (human): K213‑ub, CTLA‑4 (mouse): K213‑ub, CTLA‑4 (rat): K213‑ub
Characterization
Methods used to characterize site in vivo immunoprecipitation, western blotting
Disease tissue studied:  melanoma skin cancer
Relevant cell lines - cell types - tissues:  A2058 (keratinocyte), HeLa S3 Flp-In, T lymphocyte-spleen
Cellular systems studied:  primary cells
Species studied:  human, mouse
Upstream Regulation
Potential in vivo enzymes for site: 
Type Enzyme Evidence Notes
DEUBIQUITINASE USP8 (human) transfection of inactive enzyme, transfection of wild-type enzyme, co-immunoprecipitation, siRNA inhibition of enzyme
Comments:  K63, K27, and K29 linkages mixture may contribute to the rapidity of protein turnover
Downstream Regulation
Effect of modification (function):  enzymatic activity, induced, protein degradation
Comments:  Catalytic activity and endosomal localization of USP8 are necessary for CTLA-4 deubiquitylation of K63,K27, and K29 linked attached chains for degradation, and rapid turnover of CTLA-4